Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis

OBJECTIVES: A number of randomised control trials (RCTs) investigating the effects of long-acting somatostatin analogues in autosomal dominant polycystic kidney disease (ADPKD) and polycystic liver disease (PLD) have been recently reported. We sought to evaluate all available RCTs investigating the...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Joshua, Mills, Mark T, Ong, Albert CM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955551/
https://www.ncbi.nlm.nih.gov/pubmed/31924636
http://dx.doi.org/10.1136/bmjopen-2019-032620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955551/
https://www.ncbi.nlm.nih.gov/pubmed/31924636
http://dx.doi.org/10.1136/bmjopen-2019-032620

Ejemplares similares